9.4969
前日終値:
$9.23
開ける:
$9.32
24時間の取引高:
366.29K
Relative Volume:
0.43
時価総額:
$335.13M
収益:
$2.07M
当期純損益:
$-47.68M
株価収益率:
-3.3677
EPS:
-2.82
ネットキャッシュフロー:
$-31.31M
1週間 パフォーマンス:
+11.57%
1か月 パフォーマンス:
-7.18%
6か月 パフォーマンス:
-41.06%
1年 パフォーマンス:
-10.85%
Delcath Systems Inc Stock (DCTH) Company Profile
名前
Delcath Systems Inc
セクター
電話
(518) 743-8892
住所
566 QUEENSBURY AVENUE, QUEENSBURY, NY
DCTH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
DCTH
Delcath Systems Inc
|
9.49 | 325.95M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
128.82 | 222.66B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
101.35 | 150.26B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
372.03 | 143.44B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
105.42 | 135.12B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
86.92 | 50.38B | 5.88B | 1.34B | 799.60M | 2.3489 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-28 | 開始されました | Craig Hallum | Buy |
| 2024-05-14 | 開始されました | Stephens | Overweight |
| 2022-07-26 | 再開されました | Canaccord Genuity | Buy |
| 2021-12-10 | 開始されました | H.C. Wainwright | Buy |
| 2021-03-09 | 開始されました | Canaccord Genuity | Buy |
| 2021-01-05 | 開始されました | BTIG Research | Buy |
| 2020-06-01 | 開始されました | Laidlaw | Buy |
すべてを表示
Delcath Systems Inc (DCTH) 最新ニュース
Do Options Traders Know Something About Delcath Systems Stock We Don't? - Yahoo Finance
Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH) and ClearPoint Neuro (CLPT) - The Globe and Mail
Delcath Systems (NASDAQ:DCTH) Board Authorizes Stock Repurchase Plan - MarketBeat
Responsive Playbooks and the DCTH Inflection - news.stocktradersdaily.com
Delcath Systems authorizes $25 million share repurchase program - MSN
Why We're Not Concerned Yet About Delcath Systems, Inc.'s (NASDAQ:DCTH) 28% Share Price Plunge - simplywall.st
Delcath Systems authorizes $25 million share repurchase program By Investing.com - Investing.com Canada
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program - BioSpace
How supply shortages influence Delcath Systems Inc. (DV3R) stockEarnings Growth Summary & Entry and Exit Point Strategies - newser.com
Biotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound - Nasdaq
Delcath Systems board authorizes $25 million share repurchase program By Investing.com - Investing.com Australia
Delcath Systems board authorizes $25 million share repurchase program - Investing.com India
Delcath Systems (DCTH) Initiates $25 Million Share Buyback Progr - GuruFocus
Delcath Systems Announces $25M Share Buyback Plan - TipRanks
[8-K] DELCATH SYSTEMS, INC. Reports Material Event | DCTH SEC FilingForm 8-K - Stock Titan
Delcath Systems, Inc. announces an Equity Buyback for $25 million worth of its shares. - MarketScreener
Delcath Systems board of directors authorizes $25 million share repurchase program - MarketScreener
Domino's Pizza (Nasdaq: DPZ) brings back $9.99 any-topping pizzas promotion - Stock Titan
Can Delcath Systems Inc. (DV3R) stock beat analyst consensusWeekly Trade Analysis & Consistent Profit Trade Alerts - newser.com
Can Delcath Systems Inc. (DV3R) stock attract ESG investmentsWeekly Loss Report & Technical Analysis for Trade Confirmation - newser.com
What analyst consensus says on Delcath Systems Inc. stockBear Alert & Verified Trade Idea Suggestions - newser.com
Forecasting Delcath Systems Inc. price range with options dataJuly 2025 Momentum & Risk Managed Investment Entry Signals - newser.com
How Delcath Systems Inc. (DV3R) stock reacts to Fed tighteningDollar Strength & Free Reliable Trade Execution Plans - newser.com
Delcath Systems Shares Tick Higher After Study Highlights Strong Outcomes for Liver Cancer Treatment - MSN
Will Delcath Systems Inc. stock reach all time highs in 2025Market Performance Recap & AI Driven Stock Price Forecasts - newser.com
Real time breakdown of Delcath Systems Inc. stock performanceJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Why Delcath Systems Inc. (DV3R) stock trades below fair value2025 Valuation Update & Weekly High Return Opportunities - newser.com
Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma - BioSpace
Is Delcath Systems Inc. showing signs of accumulation - newser.com
Will Delcath Systems Inc. benefit from macro trends2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Will Delcath Systems Inc. (DV3R) stock issue positive guidanceMarket Sentiment Review & Risk Adjusted Buy/Sell Alerts - newser.com
Volatility clustering patterns for Delcath Systems Inc.Breakout Watch & Free Growth Oriented Trading Recommendations - newser.com
Delcath Systems, Inc. authorizes a Buyback Plan. - MarketScreener
Delcath Systems (DCTH) Highlights Promising Results for Liver Me - GuruFocus
H.C. Wainwright Reiterates a Buy on Delcath Systems (DCTH), Lowers the PT - Insider Monkey
Delcath Systems Inc (DCTH) 財務データ
収益
当期純利益
現金流量
EPS
Delcath Systems Inc (DCTH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| MICHEL GERARD J | CHIEF EXECUTIVE OFFICER |
Nov 11 '25 |
Buy |
8.53 |
11,500 |
98,049 |
330,834 |
| Vukovic Vojo | CHIEF MEDICAL OFFICER |
Jun 12 '25 |
Option Exercise |
4.78 |
42,000 |
200,760 |
168,882 |
大文字化:
|
ボリューム (24 時間):